Related Experiment Videos

Tissue plasminogen activator for occluded peritoneal dialysis catheter

Abdullah Sakarcan1, James R Stallworth

  • 1Department of Pediatrics, Division of Pediatric Nephrology, University of South Carolina School of Medicine, Eight Medical Park, Columbia, SC 29203, USA. abdullahsakarcan@hotmail.com

Insights

Tissue plasminogen activator effectively resolved malfunctioning peritoneal dialysis catheters in a pediatric patient. This treatment offers a solution for inadequate catheter flow in children undergoing dialysis.

Area of Science:

  • Pediatric Nephrology
  • Medical Device Engineering

Background:

  • Peritoneal dialysis is a crucial treatment for pediatric end-stage renal disease.
  • Malfunctioning peritoneal dialysis catheters, often due to inadequate flow, present a significant challenge in pediatric care.

Observation:

  • Inadequate flow in a peritoneal catheter is a frequent complication in pediatric patients undergoing peritoneal dialysis.
  • This necessitates interventions to restore catheter function and ensure treatment efficacy.

Findings:

  • Intra-catheter administration of tissue plasminogen activator (tPA) was effective in resolving a malfunctioning peritoneal dialysis catheter in a pediatric case.
  • The study demonstrates successful restoration of adequate catheter flow using tPA.

Implications:

  • Intra-catheter tPA represents a promising, minimally invasive therapeutic option for pediatric peritoneal dialysis catheter dysfunction.
  • This approach may improve treatment adherence and outcomes for children requiring peritoneal dialysis.

Related Concept Videos